Liver masses;Der leberrundherd

Deutsches Arzteblatt

Volumn 104, Issue 33, 2007, Pages

  Spangenberg, Hans C ^a,b   Thimme, Robert ^a   Blum, Hubert E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Computed tomography; Focal nodular hyperplasia; Hepatocellular carcinoma; Liver cell adenoma; Ultrasonography

Indexed keywords

ANTINEOPLASTIC AGENT; GEMCITABINE; SORAFENIB;

BILE DUCT CARCINOMA; CANCER RESEARCH; CANCER SURGERY; CAVERNOUS HEMANGIOMA; CLINICAL FEATURE; CLINICAL TRIAL; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MIXED TUMOR; MORBIDITY; NODULAR HYPERPLASIA; REVIEW; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 34548676626     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Ros PR, Li KC: Benign liver tumors. Curr Probl Diagn Radiol 1989; 18: 125-55.
2. Ito K, Honjo K, Fujita T et al.: Liver neoplasms: diagnostic pitfalls in cross-sectional imaging. Radiographics 1996; 16: 273-93.
3. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr.: Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. Jama 1979; 242: 644-8.
4. Wilkens L, Bredt M, Flemming P, Becker T, Klempnauer J, Kreipe HH: Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2001; 193: 476-82.
5. Bioulac-Sage P, Balabaud C, Wanless IR: Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol 2001; 25: 1322-5.
6. Klatskin G: Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 1977; 73: 386-94.
7. Mettlin C, Natarajan N: Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors. J Surg Oncol 1981; 18: 73-85.
8. Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194-200.
9. Devaney K, Goodman ZD, Ishak KG: Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18: 1078-91.
10. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127(5 Suppl 1): S5-16.
11. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218-24.
12. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM: Obesity and hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1): S97-103.
13. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8.
14. Malhi H, Gores GJ: Cholangiocarcinoma:modern advances in understanding a deadly old disease. J Hepatol 2006; 45: 856-67.
15. Spangenberg HC, Thimme R, Blum HE: Serum markers of hepatocelllar carcinoma. Semin Liver Dis 2006; 26: 385-90.
16. Lim JH, Park CK: Pathology of cholangiocarcinoma. Abdom Imaging 2004; 29: 540-7.
17. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney D, Ritts RE: Diagnostic role of serum CA 19-9in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993; 68: 874-879.
18. Boozari B, Lotz J, Galanski M, Gebel M: Diagnostic imaging of liver tumors. Current status. Internist 2007; 48: 8-20.
19. Bruix J, Sherman M, Llovet JM et al.: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
20. Lang H, Broelsch CE: Liver resection and transplantation for hepatic tumors. Internist 2007; 48: 30-9.
21. Mohr L: Hepatocellular carcinoma. Therapeutic perspectives. Der Gastroenterologe 2007; 2: 34-9.
22. Spangenberg HC: Local ablative therapy. Der Gastroenterologe 2007; 2: 27-33.
23. Strey CW, Zapletal C, Bechstein WO: Surgical therapy of hepatocelllar carcinoma. Der Gastroenterologe 2007; 2: 19-6.
24. Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
25. Malek NP, Greten T, Kubicka S: Systemic tretament of liver and bilary tumors. Internist 2007; 48: 46-50.